Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-25T18:20:43.636Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease

Published online by Cambridge University Press:  28 February 2007

Michelle C. McKinley
Michelle C. McKinley*
Affiliation:
Northern Ireland Centre for Diet and Health, University of Ulster, Coleraine BT52 1SA, UK
*
*Corresponding author: Dr Michelle McKinley, fax +44(0)1265 324965, email MC.McKinley@ulst.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Numerous case–control and prospective studies have identified elevated plasma homocysteine as a strong independent risk factor for cerebovascular, cardiovascular and peripheral vascular disease. Homocysteine is formed as a result of the breakdown of the dietary amino acid methionine. Once formed, homocysteine is either remethylated to methionine, or undergoes a trans-sulfuration reaction to form cysteine. The re-methylation of homocysteine to methionine is dependent on three B-vitamins, i.e. riboflavin, vitamin B12 and folate. The second pathway of homocysteine metabolism is the trans-sulfuration pathway which requires both vitamin B6 and riboflavin for its activity. Thus, up to four B-vitamins are required for intracellular homocysteine metabolism. Many studies have noted strong inverse relationships between homocysteine levels and the status of both vitamin B12 and folate. However, the relationship between vitamin B6 status and homocysteine is still uncertain. Similarly, numerous intervention studies have demonstrated effective lowering of homocysteine levels as a result of folate and vitamin B12 supplementation, while the homocysteine-lowering ability of vitamin B6 is unclear. Even though riboflavin plays a crucial role in both the trans-sulfuration and remethylation pathways of homocysteine metabolism, the relationship between riboflavin status and homocysteine levels has not been investigated. The exact mechanism that explains the vascular toxicity of elevated homocysteine levels is unknown at present, studies indicate that it is both atherogenic and thrombogenic. To date, no randomized clinical trial has demonstrated that lowering of homocysteine levels is beneficial in terms of reducing the prevalence of vascular disease. It is probable, however, that optimal B-vitamin status is important in the prevention of vascular disease.

Keywords

HomocysteineVascular diseaseVitamin B
Type
Postgraduate Symposium
Information
Proceedings of the Nutrition Society , Volume 59 , Issue 2 , May 2000 , pp. 221 - 237
Copyright
Copyright © The Nutrition Society 2000

References

Alfthan, G, Pekkanen, J, Jauhiainen, M, Pitkaniemi, J, Karvonen, M, Tuomilehto, J, Salonen, JT & Ehnholm, C (1994) Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106, 9–19.CrossRefGoogle Scholar
Allen, RH, Stabler, SP, Savage, DG & Lindenbaum, J (1990) Diagnosis of cobalamin deficiency I: Usefulness of serum methylmalonic acid and total homocysteine concentration. American Journal of Hematology 34, 90–98.CrossRefGoogle Scholar
Ambrosi, P, Barlatier, A, Habib, G, Garcon, D, Kreitman, B, Roland, PH, Saingra, S, Metras, D & Luccioni, R (1994) Hyperhomocysteinaemia in heart transplant recipients. European Heart Journal 15, 1191–1195.CrossRefGoogle ScholarPubMed
Andersson, A, Brattstrom, L, Israelsson, B, Isaksson, A, Hamfelt, A & Hultberg, B (1992) Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status. European Journal of Clinical Investigation 22, 79–87.CrossRefGoogle ScholarPubMed
Andersson, A, Lindgren, A & Hultberg, B (1995) Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction. Clinical Chemistry 41, 361–366.CrossRefGoogle ScholarPubMed
Anker, G, Lonning, PE, Ueland, PM, Refsum, H & Lien, EA (1995) Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. International Journal of Cancer 60, 365–368.CrossRefGoogle ScholarPubMed
Arnadottir, M, Brattstrom, L, Simonsen, O, Thysell, H, Hultberg, B, Andersson, A & Nillson-Ehle, P (1993) The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clinical Nephrology 40, 236–240.Google ScholarPubMed
Arnadottir, M, Hultberg, B, Vladov, V, Nisson-Ehle, P & Thysell, H (1996) Hyperhomocysteinemia in cyclosporin-treated renal transplant recipients. Transplantation 61, 509–512.CrossRefGoogle Scholar
Arnesen, E, Refsum, H, Bonaa, KH, Ueland, PM, Forde, OH & Nordrehaug, JE (1995) Serum total homocysteine and coronary heart disease. International Journal of Epidemiology 24, 704–709.CrossRefGoogle ScholarPubMed
Aronow, WS & Ahn, C (1997) Association between plasma homocysteine and coronary artery disease in older persons. American Journal of Cardiology 80, 1216–1218.CrossRefGoogle ScholarPubMed
Aronow, WS & Ahn, C (1998) Association between plasma homocysteine and peripheral arterial disease in older persons. Coronary Artery Disease 9, 49–50.CrossRefGoogle ScholarPubMed
Badner, NH, Drader, K, Freeman, D & Spence, JD (1998) The use of intraoperative nitrous oxide leads to postoperative increases in plasma homocysteine. Anesthesia and Analgesia 87, 711–713.CrossRefGoogle ScholarPubMed
Bailey, LB & Gregory, JF (1999) Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance risks and impact on folate requirement. Journal of Nutrition 129, 919–922.CrossRefGoogle ScholarPubMed
Bates, CJ & Fuller, NJ (1986) The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.20) and folate metabolism in the rat. British Journal of Nutrition 55, 455–464.CrossRefGoogle ScholarPubMed
Bates, CJ, Pentieva, KD, Prentice, A, Mansoor, MA & Finch, S (1999) Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. British Journal of Nutrition 81, 191–201.CrossRefGoogle Scholar
Bellamy, MF, McDowell, IFW, Ramsey, MW, Brownlee, M, Newcombe, RG & Lewis, MJ (1999) Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. European Journal of Clinical Investigation 29, 659–662.Google Scholar
Berger, PB, Jones, JD, Olson, LJ, Edwards, BS, Frantz, RP, Rodeheffer, RJ, Kott, BA, Daly, RC & McGregor, CGA (1995) Increase in total plasma homocysteine concentration after cardiac-transplantation. Mayo Clinic Proceedings 70, 125–131.CrossRefGoogle ScholarPubMed
Blann, AD (1992) Endothelial cell damage and homocysteine. Atherosclerosis 94, 89–91.CrossRefGoogle ScholarPubMed
Blom, HJ, Kleinveld, HA, Boers, GHJ, Demacker, PNM, Hal-Lemmers, HLM, Te Poele-Pothoff, MTWB & Trijbels, JMF (1995) Lipid peroxidation and susceptibility of low-density lipoproteins to in vitro oxidation in hyperhomocysteinaemia. European Journal of Clinical Investigation 25, 149–154.CrossRefGoogle ScholarPubMed
Boers, GH, Smals, AG, Trijbels, FJ, Leermakers, AI & Kloppenborg, PW (1983) Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. Journal of Clinical Investigation 72, 1971–1976.CrossRefGoogle ScholarPubMed
Bostom, AG & Culleton, BF (1999) Hyperhomocysteinemia in chronic renal disease. Journal of the American Society of Nephrology 10, 891–900.CrossRefGoogle ScholarPubMed
Bostom, AG, Gohh, RY, Beaulieu, AJ, Nadeau, MR, Hume, AL, Jacques, PF, Selhub, J & Rosenberg, IH (1997a) Treatment of hyperhomocysteinemia in renal transplant recipients: A randomized placebo-controlled trial. Annals of Internal Medicine 127, 1089–1092.CrossRefGoogle ScholarPubMed
Bostom, AG, Rosenberg, IH, Silbershatz, H, Jacques, PF, Selhub, J, D'Agostino, RB, Wilson, PWF & Wolf, PA (1999) Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham Study. Annals of Internal Medicine 131, 352–355.CrossRefGoogle ScholarPubMed
Bostom, AG, Shemin, D, Verhoef, P, Nadeau, MR, Jacques, PF, Selhub, J, Dworkin, L & Rosenberg, IH (1997b) Elevated fasting plasma total homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study. Arteriosclerosis, Thrombosis and Vascular Biology 17, 2554–2558.Google Scholar
Bots, ML, Launer, LJ, Lindemans, J, Hoes, AW, Hofman, A, Witteman, JCM, Koudstaal, PJ & Grobbee, DE (1999) Homocysteine and short-term risk of myocardial infarction and stroke in the elderly. Archives of Internal Medicine 159, 38–44.CrossRefGoogle ScholarPubMed
Bots, ML, Launer, LJ, Lindemans, J, Hofman, A & Grobbee, DE (1997) Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam study. Journal of Internal Medicine 242, 339–347.CrossRefGoogle ScholarPubMed
Boushey, CJ, Beresford, SAA, Omenn, GS & Motulsky, AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Journal of the American Medical Association 274, 1049–1057.Google Scholar
Brattstrom, LE, Hardebo, JE & Hultberg, BL (1984) Moderate hyperhomocysteinemia — A possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 15, 1012–1016.CrossRefGoogle ScholarPubMed
Brattstrom, LE, Hultberg, BL & Hardebo, JE (1985) Folic acid responsive postmenopausal homocysteinemia. Metabolism 34, 1073–1077.CrossRefGoogle ScholarPubMed
Brattstrom, LE, Israelsson, B, Jeppsson, JO & Hultberg, BL (1988) Folic acid – an innocuous means to reduce plasma homocysteine. Scandinavian Journal of Clinical Laboratory Investigation 48, 215–221.Google Scholar
Brattstrom, L, Israelson, B, Norrving, B, Bergqvist, D, Thorne, J, Hultberg, B & Hamfelt, A (1990) Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 81, 51–60.CrossRefGoogle ScholarPubMed
Brattstrom, L, Israelsson, B, Olsson, A, Andersson, A & Hultberg, B (1992a) Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma. Scandinavian Journal of Clinical Laboratory Investigation 52, 283–287.Google Scholar
Brattstrom, L, Lindgren, A, Israelsson, B, Andersson, A & Hultberg, B (1994) Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. Journal of Internal Medicine 236, 633–641.CrossRefGoogle ScholarPubMed
Brattstrom, L, Lindgren, A, Israelsson, B, Malinow, MR, Norrving, B, Upson, B & Hamfelt, A (1992b) Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke risk factors. European Journal of Clinical Investigation 22, 214–221.CrossRefGoogle ScholarPubMed
Brattstrom, L, Wilcken, DEI, Ohrvik, J & Brudin, L (1998) Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease – the results of a meta-analysis. Circulation 98, 2520–2526.CrossRefGoogle Scholar
Bronstrup, A, Hages, M, Prinz-Lagenohl, R & Pietrzik, K (1998) Effect of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women. American Journal of Clinical Nutrition 68, 1104–1110.Google Scholar
Carson, NAJ & Neill, DW (1962) Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Archives of Disease in Childhood 37, 505–513.Google Scholar
Celermajer, DS, Sorensen, K, Ryalls, M, Robincon, J, Thomas, O, Leonard, JV & Deanfield, JE (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. Journal of the American College of Cardiology 22, 854–858.CrossRefGoogle Scholar
Chasan-Taber, L, Selhub, J, Rosenberg, IH, Malinow, MR, Terry, P, Tishler, PV, Willett, W, Hennekens, CH & Stampfer, MJ (1996) A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. Journal of the American College of Nutrition 15, 136–143.CrossRefGoogle ScholarPubMed
Chin, JH, Azhar, S & Hoffman, BB (1992) Inactivation of endothelial derived relaxing factor by oxidised lipoprotein. Journal of Clinical Investigation 89, 10–18.CrossRefGoogle Scholar
Christensen, B, Guttormsen, AB, Schneede, J, Riedel, B, Refsum, H, Svardal, A & Ueland, PM (1993) Preoperative methionine loading enhances restoration of the cobalamin-dependent enzyme methionine synthase after nitrous oxide anaesthesia. Anesthesiology 80, 1046–1056.CrossRefGoogle Scholar
Clarke, R, Daly, L, Robinson, K, Naughton, E, Cahalane, S, Fowler, B & Graham, I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. New England Journal of Medicine 324, 1149–1155.CrossRefGoogle ScholarPubMed
Clarke, R & Homocysteine Lowering Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. British Medical Journal 316, 894–898.CrossRefGoogle Scholar
Clarke, R, Smith, AD, Jobst, KA, Refsum, H, Sutton, L & Ueland, PM (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer's Disease. Archives of Neurology 55, 1449–1455.CrossRefGoogle Scholar
Dalery, K, Lussier-Cacan, S, Selhub, J, Davignon, J, Latour, Y & Genest, J (1995) Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folate. American Journal of Cardiology 75, 1107–1111.CrossRefGoogle ScholarPubMed
Daly, LE, Kirke, PN, Molloy, A, Weir, DG & Scott, JM (1995) Folate levels and neural tube defects. Implications for prevention. Journal of the American Medical Association 274, 1698–1702.CrossRefGoogle ScholarPubMed
De Groot, PG, Willems, C, Boers, GHJ, Gonsalves, MD, van Aken, WG & van Mourik, JA (1983) Endothelial cell dysfunction in homocystinuria. European Journal of Clinical Investigation 13, 405–410.Google Scholar
De, Laet C, Wautrecht, J-C, Brausseur, D, Dramaix, M, Boeynaems, J-M, Decuyper, J & Kahn, A (1999) Plasma homocysteine concentrations in a Belgian school-age population. American Journal of Clinical Nutrition 69, 968–972.Google Scholar
Den, Heijer M, Koster, T, Blom, HJ, Bos, GMJ, Briet, E, Reitsma, PH, Vandenbroucke, JP & Rosenblatt, FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine 334, 759–762.Google Scholar
Diaz-Arrastia, R (1998) Hyperhomocysteinemia: a new risk factor for Alzheimer's Disease. Archives of Neurology 55, 1407–1408.CrossRefGoogle Scholar
Dierkes, J, Kroesen, M & Pietrzik, K (1998) Folic acid and vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women. International Journal of Vitamin and Nutrition Research 68, 98–103.Google ScholarPubMed
Domagala, TB, Libura, M & Szczeklik, A (1997) Hyperhomocysteinemia following an oral methionine load is associated with increased lipid peroxidation. Thrombosis Research 87, 411–416.CrossRefGoogle ScholarPubMed
Dudman, NPB, Hicks, C, Wang, J & Wilcken, DEL (1991) Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 91, 77–83.CrossRefGoogle ScholarPubMed
Dudman, NPB, Temple, SE, Guo, XW, Fu, W & Perry, MA (1999) Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circulation Research 84, 409–416.CrossRefGoogle ScholarPubMed
Dudman, NPB, Wilcken, DEL & Stocker, R (1993) Circulating lipid hydroperoxide levels in human hyperhomocysteinemia: Relevance to development of arteriosclerosis. Arteriosclerosis and Thrombosis 13, 512–516.CrossRefGoogle ScholarPubMed
Dudman, NPB, Wilcken, DEL, Wang, J, Lynch, JF, Macey, D & Lundberg, P (1993) Disordered methionine/homocysteine metabolism in premature vascular disease: its occurrence, cofactor therapy, and enzymology. Arteriosclerosis and Thrombosis 13, 1253–1260.CrossRefGoogle ScholarPubMed
Du Vigneaud, VE (1952) Trail of Research in Sulfur Chemistry and Metabolism, and Related Fields. Ithaca, NY: Cornell University Press.Google Scholar
Editorial (1981) Is vitamin B-6 an anti-thrombotic agent? Lancet i, 1299.Google Scholar
Eichinger, S, Stumpflen, A, Hirschi, M, Bialonczyk, C, Herkner, K, Stain, M, Schneider, B, Pabinger, I, Lechner, K & Kyrle, AA (1998) Hyperhomocysteinemia is a risk factor for recurrent venous thromboembolism. Thrombosis and Haemostasis 80, 566–569.Google ScholarPubMed
Eikelboom, JW, Lonn, E, Genest, J, Hankey, G & Yusuf, S (1999) Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence. Annals of Internal Medicine 131, 363–375.CrossRefGoogle ScholarPubMed
Emsley, AM, Jeremy, JY, Gomes, GN, Angeline, GD & Plane, F (1999) Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. British Journal of Pharmacology 126, 1034–1040.CrossRefGoogle ScholarPubMed
Ermens, AAM, Refsum, H & Rupreht, J (1991) Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine. Clinical Pharmacological Therapy 49, 385–393.CrossRefGoogle ScholarPubMed
Evans, RW, Shaten, J, Hempel, JD, Cutler, JA & Kuller, LH (1997) Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial. Arteriosclerosis, Thrombosis and Vascular Biology 17, 1947–1953.CrossRefGoogle ScholarPubMed
Fekkes, D, van der, Cammen TJM, van Loon, CPM, Verschoor, C, van Harskamp, F, de Koning, I, Schudel, WJ & Pepplinkhuizen, L (1998) Abnormal amino acid metabolism in patients with early stage Alzheimer dementia. Journal of Neural Transmission 105, 287–294.CrossRefGoogle ScholarPubMed
Fenton, WA & Rosenberg, LE (1995) Inherited disorders of cobalamin transport and metabolism. In The Metabolic Basis of Inherited Disease, 7th ed., pp. 3129–3149 [Scriver, CR, Beaudet, AL, Sly, WS & Valle, D, editors]. New York: McGraw-Hill.Google Scholar
Ferguson, E, Hogg, N, Antholine, WE, Joseph, J, Singh, RJ, Parthasarathy, S & Kalyanaraman, B (1999) Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: Antioxidant implications. Free Radical Biology and Medicine 26, 968–977.CrossRefGoogle ScholarPubMed
Finkelstein, JD (1990) Methionine metabolism in mammals. Journal of Nutritional Biochemistry 1, 228–237.CrossRefGoogle ScholarPubMed
Folsom, AR, Nieto, J, McGovern, PG, Tsai, MY, Malinow, MR, Eckfeldt, JH, Hess, DL & Davis, CE (1998) Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: The atherosclerosis risk in communities (ARIC) study. Circulation 98, 204–210CrossRefGoogle Scholar
Food and Drug Administration (1996) Food standards: amendment of standards of identity for enriched grain products to require the addition of folic acid. Federal Registry 61, 8781–8809.Google Scholar
Freyburger, G, Labrouche, S, Sassoust, G, Rouanet, F, Javorschi, S & Parrot, F (1997) Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular disease. Thrombosis and Haemostasis 77, 466–471.Google Scholar
Frosst, P, Blom, HJ, Milos, R, Goyette, P, Sheppard, CA, Matthews, RG, Boers, GHJ, den, Heijer M, Kluijtmans, LAJ, van den, Heuvel LP & Rozen, R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics 10, 111–113.CrossRefGoogle ScholarPubMed
Fryer, RH, Wilson, BD, Gubler, DB, Fitzgerald, LA & Rodgers, GM (1993) Homocysteine as a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Atherosclerosis and Thrombosis 13, 1327–1333.Google ScholarPubMed
Garg, UD & Hassid, A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis amd proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation 93, 1774–1777.CrossRefGoogle Scholar
Gerritsen, T & Waisman, HA (1964) Homocystinuria, an error in the metabolism of methionine. Pediatrics 33, 413–420.CrossRefGoogle Scholar
Goodman, SI, Moe, PG, Hammond, KB, Mudd, SH & Uhlendorf, BW (1970) Homocystinuria with methylmalonic aciduria: two cases of a sibship. Biochemical Medicine 4, 500–515.CrossRefGoogle ScholarPubMed
Graeber, JE, Slott, JH, Ulane, RE, Schulman, JD & Stuart, MJ (1982) Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism. Pediatric Research 16, 490–493.CrossRefGoogle ScholarPubMed
Graham, IM, Daly, LE, Refsum, HM, Robinson, K, Brattstrom, LE, Ueland, PM, Palma-Reis, RJ & Boers, GHJ (1997) Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. Journal of the American Medical Association 277, 1775–1781.CrossRefGoogle ScholarPubMed
Greenlund, KJ, Srinivasan, SR, Xu, J-H, Dalferes, E, Myers, L, Pickoff, A & Berenson, GS (1999) Plasma homocysteine distribution and its association with parental history of coronary artery disease in black and white children: The Bogalusa Heart Study. Circulation 99, 2144–2149.CrossRefGoogle ScholarPubMed
Gudnason, V, Stansbie, D, Scott, J, Bowron, A, Nicaud, V & Humphries, S (1998) C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis 136, 347–354.CrossRefGoogle Scholar
Guenther, BD, Sheppard, CA, Tran, P, Rozen, R, Matthews, RG & Ludwig, ML (1999) The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nature Structural Biology 6, 359–365.Google ScholarPubMed
Gupta, A, Moustapha, A, Jacobsen, DW, Goormastic, M, Tuzcu, EM, Hobbs, R, Young, J, James, K, McCarthy, P, van Lente, F, Green, R & Robinson, K (1998) High homocysteine, low folate, and low vitamin B6 concentration — prevalent risk factors for vascular disease in heart transplant recipients. Transplantation 65, 544–550.CrossRefGoogle Scholar
Guttormsen, AB, Ueland, PM, Nesthus, I, Nygard, O, Schneede, J, Vollset, SE & Refsum, H (1996) Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> 40 mmol/liter). The Hordaland Homocysteine Study. Journal of Clinical Investigation 98, 2174–2183.CrossRefGoogle Scholar
Hajjar, KA (1993) Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. Journal of Clinical Investigation 91, 2873–2879.CrossRefGoogle ScholarPubMed
Hajjar, KA, Mauri, L, Jacovina, AT, Zhong, F, Mirza, VA, Padovan, JC & Chait, BT (1998) Tissue plasminogen activator binding to the annexin II tail domain. Journal of Biological Chemistry 273, 9987–9993.CrossRefGoogle Scholar
Hamfelt, A & Soderhjelm, L (1988) Vitamin B-6 and aging. In Clinical and Physiological Applications of Vitamin B-6, pp. 95–107 (Leklem, JE & Reynolds, RD, editors]. New York: Alan R. Liss Inc.Google Scholar
Harker, LA, Harlan, JM & Ross, R (1983) Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circulation Research 53, 731–739.CrossRefGoogle ScholarPubMed
Harker, LA, Ross, R, Slichter, SJ & Scott, CR (1976) Homocysteine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. Journal of Clinical Investigation 58, 731–741.CrossRefGoogle Scholar
Harker, LA, Slichter, SJ, Scott, CR & Ross, R (1974) Homocystinuria: Vascular injury and arterial thrombosis. New England Journal of Medicine 291, 537–543.CrossRefGoogle ScholarPubMed
Harmon, DL, Woodside, JV, Yarnell, JWG, McMaster, D, Young, IS, McCrum, EE, Gey, KF, Whitehead, AS & Evans, AE (1996) The common ‘thermolabile’ variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Quarterly Journal of Medicine 89, 571–577.CrossRefGoogle Scholar
Harpel, PC, Chang, VT & Borth, W (1992) Homocysteine and other sulfydryl compounds enhance the binding of lipoprotein (a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfydryl compound metabolism. Proceedings of the National Academy of Sciences USA 89, 10193–10197.CrossRefGoogle Scholar
Hayashi, T, Honda, G & Suzuki, K (1992) An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood 79, 2930–2936.CrossRefGoogle ScholarPubMed
Healy, H, Booth, C, Clague, A & Wesyhuyzen, J (1998) Hyperhomocysteinaemia in end-stage renal failure patients: Effect of low-dose supplementation with folic acid. Nephrology 4, 413–418.CrossRefGoogle Scholar
Heijmans, BT, Gussekloo, J, Kluft, C, Droog, S, Lagaay, AM, Knook, DL, Westendorp, RGJ & Slagboom, EP (1999) Mortality risk in men is associated with a common mutation in the methylenetetrahydrofolate reductase gene (MTHFR). European Journal of Human Genetics 7, 197–204.CrossRefGoogle Scholar
Heinecke, JW, Rosen, H, Suzuki, LA & Chait, A (1987) The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. Journal of Biological Chemistry 262, 10098–10103.CrossRefGoogle ScholarPubMed
Hladovec, J (1979) Experimental homocystinemia, endothelial lesions and thrombosis. Blood Vessels 16, 202–205.Google ScholarPubMed
Hoffman, RM (1985) Altered methionine metabolism and transmethylation in cancer. Anticancer Research 5, 1–30.Google ScholarPubMed
Hopkins, PN, Wu, LL, Wu, J, Hunt, SC, James, BC, Michael, Vincent G & Williams, RR (1995) Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arteriosclerosis, Thrombosis and Vascular Biology 15, 1314–1320.CrossRefGoogle Scholar
Israelsson, B, Brattstrom, LE & Hultberg, BL (1988) Homocysteine and myocardial infarction. Atherosclerosis 71, 227–233.CrossRefGoogle Scholar
Jacobsen, DW (1998) Acquired hyperhomocysteinemia in heart transplant recipients. Clinical Chemistry 44, 2238–2239.CrossRefGoogle ScholarPubMed
Jacques, PF, Bostom, AG, Williams, RR, Ellison, RC, Eckfeldt, JH, Rosenberg, IH, Selhub, J & Rozen, R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations Circulation 93, 7–9.CrossRefGoogle ScholarPubMed
Jacques, PF, Selhub, J, Bostom, AG, Wilson, PWF & Rosenberg, IH (1999) The effect of folic acid fortification on plasma folate and total homocysteine concentrations. New England Journal of Medicine 340, 1449–1454.CrossRefGoogle ScholarPubMed
Jakubowski, H (1997) Metabolism of homocysteine thiolactone in human cell cultures: Possible mechanism for pathological consequences of elevated homocysteine levels. Journal of Biological Chemistry 272, 1935–1942.CrossRefGoogle ScholarPubMed
Kang, S-S, Wong, PWK, Cook, HM, Norusis, M & Messer, JV (1986a) Protein-bound homocyst(e)ine: A possible risk factor for coronary artery disease. Journal of Clinical Investigation 77, 1482–1486.CrossRefGoogle ScholarPubMed
Kang, S-S, Wong, PWK & Curley, K (1982) The effect of D-penicillamine on protein-bound homocyst(e)ine in homocystinurics. Pediatric Research 16, 370–372.CrossRefGoogle ScholarPubMed
Kang, S-S, Wong, PWK, Glickman, PB, MacLeod, CM & Jaffe, IA (1986b) Protein-bound homocyst(e)ine in patients with rheumatoid arthritis undergoing D-penicillamine treatment. Journal of Clinical Pharmacology 26, 712–715.CrossRefGoogle ScholarPubMed
Kang, S-S, Wong, PWK & Malinow, MR (1992) Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annual Review of Nutrition 12, 279–298.CrossRefGoogle ScholarPubMed
Kang, S-S, Wong, PWK & Norusis, M (1987) Homocysteinemia due to folate deficiency. Metabolism 36, 458–462.CrossRefGoogle ScholarPubMed
Kark, JD, Selhub, J, Adler, B, Gofin, J, Abramson, JH, Friedman, G & Rosenberg, IH (1999) Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Annals of Internal Medicine 131, 321–330.CrossRefGoogle ScholarPubMed
Keaney, JF & Loscalzo, J (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. Journal of Biological Chemistry 272, 17012–17017.Google Scholar
Koehler, KM, Romero, LJ, Stauber, PM, Parreo-Tubbeh, SL, Liang, HC, Baumgartner, RN, Garry, PJ, Allen, RH & Stabler, SP (1996) Vitamin supplementation and other variables affecting serum homocysteine and methylmalonic acid concentration in elderly men and women. Journal of the American College of Nutrition 15, 364–376.CrossRefGoogle ScholarPubMed
Konecki, E & Feinberg, H (1980) Pyridoxal phosphate inhibition of platelet function. American Journal of Physiology 238, H54–H60.Google Scholar
Konecky, N, Malinow, MR, Tunick, PA, Freedberg, RS, Rosenzweig, BP, Katz, ES, Hess, DL, Upson, B, Leung, B, Perez, J & Kronson, I (1997) Correlation between plasma homocyst(e)ine and aortic atherosclerosis. American Heart Journal 133, 534–540.CrossRefGoogle ScholarPubMed
Kokame, K, Kato, H & Miyata, T (1996) Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. Journal of Biological Chemistry 271, 29659–29665.CrossRefGoogle ScholarPubMed
Kraus, JP (1998) Biochemistry and molecular genetics of cystathionine b-synthase deficiency. European Journal of Pediatrics 157, Suppl. 2, S50–S53.CrossRefGoogle Scholar
Lakshmi, AV & Ramalakshmi, BA (1998) Effect of pyridoxine or riboflavin supplementation on plasma homocysteine levels in women with oral lesions. National Medical Journal of India 11, 171–172.Google ScholarPubMed
Lam, SC, Harfenist, EJ, Packham, MA & Mustard, JF (1980) Investigation of possible mechanisms of pyridoxal 5>-phosphate inhibition of platelet reactions. Thrombosis Research 20, 633–645.CrossRefGoogle ScholarPubMed
Landgren, F, Israelsson, B, Lindgren, A, Hultberg, B, Andersson, A & Brattstrom, L (1995) Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acid. Journal of Internal Medicine 237, 381–388.CrossRefGoogle ScholarPubMed
Lentz, SR & Sadler, JE (1991) Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. Journal of Clinical Investigation 88, 1906–1914.CrossRefGoogle Scholar
Lentz, SR & Sadler, JE (1993) Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood 81, 683–689.CrossRefGoogle ScholarPubMed
Lentz, SR, Sobey, CG, Piegors, DJ, Bhopatkar, MY, Faraci, FM, Malinow, MR & Helstad, DD (1996) Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. Journal of Clinical Investigation 98, 24–29.CrossRefGoogle ScholarPubMed
Levy, HL, Mudd, SH, Schulman, JD, Dreyfus, PM & Abeles, RH (1970) A derangement in B12 metabolism associated with homocystinemia, cystathioninemia, hypomethioninemia and methylmalonic aciduria. American Journal of Medicine 48, 390–397.CrossRefGoogle ScholarPubMed
Liao, JK, Shin, WS, Lee, WY & Clark, SL (1995) Oxidised low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. Journal of Biological Chemistry 270, 319–324.CrossRefGoogle ScholarPubMed
Lindgren, A, Brattstrom, L, Norrving, B, Hultberg, B, Andersson, A & Johansson, BB (1995) Plasma homocysteine in the acute and convalescent phases after stroke. Stroke 26, 795–800.CrossRefGoogle ScholarPubMed
Loscalzo, J (1996) The oxidant stress of hyperhomocyst(e)inemia. Journal of Clinical Investigation 98, 5–7.CrossRefGoogle ScholarPubMed
Lubec, B, Ladudova, O, Hoeger, H, Muetil, A, Fang-Kircher, S, Marx, M, Mosgoeller, W & Gialamac, J (1996) Homocysteine increases cyclin-dependent kinase in aortic rat tissue. Circulation 94, 2620–2625.CrossRefGoogle ScholarPubMed
McCaddon, A, Davies, G & Hudson, P (1998) Total serum homocysteine in senile dementia of the Alzheimers type. International Journal of Geriatric Psychiatry 13, 235–239.3.0.CO;2-8>CrossRefGoogle ScholarPubMed
McCormick, DB (1989) Two interconnected B vitamins: riboflavin and pyridoxine. Physiology Reviews 69, 1170–1198.CrossRefGoogle ScholarPubMed
McCully, KS (1969) Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. American Journal of Pathology 56, 111–128.Google ScholarPubMed
Ma, J, Stampfer, MJ, Hennekens, CH, Frosst, P, Selhub, J, Horsford, J, Malinow, MR, Willett, WC & Rozen, R (1996) Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94, 2410–2416.CrossRefGoogle ScholarPubMed
Malinow, MR, Ducimetiere, P, Luc, G, Evans, AE, Arveiler, D, Cambien, F & Upson, BM (1996) Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease. Atherosclerosis 126, 27–34.CrossRefGoogle ScholarPubMed
Malinow, MR, Kang, SS, Taylor, LM, Wong, PWK, Coull, B, Inahara, T, Mukerjee, D, Sexton, G & Upson, B (1989) Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 79, 1180–1188.CrossRefGoogle ScholarPubMed
Malinow, MR, Nieto, FJ, Szklo, M, Chambless, LE & Bond, G (1993) Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. Circulation 87, 1107–1113.CrossRefGoogle ScholarPubMed
Mansoor, MA, Bergmark, C, Svardal, AM, Lonning, PE & Ueland, PM (1995) Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arteriosclerosis, Thrombosis and Vascular Biology 15, 232–240.CrossRefGoogle ScholarPubMed
Mansoor, MA, Kristensen, O, Hervig, T, Bates, CJ, Pentieva, K, Vefring, H, Osland, A, Berge, T, Drablos, PA, Hetland, O & Rolfsen, S (1999) Plasma total homocysteine response to oral doses of folic acid and pyridoxine hydrochloride (vitamin B6) in healthy individuals. Oral doses of vitamin B6 reduce concentrations of serum folate. Scandinavian Journal of Clinical Laboratory Investigation 59, 139–146.CrossRefGoogle ScholarPubMed
Marks, DSJA, Vita, JD, Folts, JF, Keaney, GN Jr & Loscalzo, J (1995) Inhibition of neoitimal proliferation in rabbits following vascular injury by a single treatment with a protein adduct of nitric oxide. Journal of Clinical Investigation 96, 141–149.CrossRefGoogle Scholar
Markus, HS, Nadira, A, Swaminathan, R, Sankaralingham, A, Molloy, J & Powell, J (1997) A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischaemic cerebrovascular disease. Stroke 28, 1739–1743.CrossRefGoogle Scholar
Massy, ZA, Chadefaux-Vekemans, B, Chevalier, A, Bader, CA, Drueke, TB, Legendre, C, Lacour, B, Kamoun, P & Kreis, H (1994) Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrology Dialysis Transplantation 9, 1103–1108.CrossRefGoogle ScholarPubMed
Massy, ZA, Mamzer-Bruneel, M-F, Chevalier, A, Millet, P, Helenon, O, Chadefaux-Vekemans, B, Legendre, C, Bader, C, Drueke, T, Lacour, B & Kreis, H (1998) Carotid atherosclerosis in renal transplant recipients. Nephrology Dialysis Transplantation 13, 1792–1798.CrossRefGoogle ScholarPubMed
Miller, JW (1999) Homocysteine and Alzheimer's disease. Nutrition Reviews 57, 126–129.Google ScholarPubMed
Miller, JW, Nadeau, MR, Smith, D & Selhub, J (1992) Folate deficiency Vs vitamin B6 deficiency: comparison of responses to methionine loading. American Journal of Clinical Nutrition 59, 1033–1039.CrossRefGoogle Scholar
Molloy, AM, Daly, S, Mills, JL, Kirke, PN, Whitehead, AS, Ramsbottom, D, Conley, MR, Weir, DG & Scott, JS (1997) Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet 349, 1591–1593.CrossRefGoogle Scholar
Montalescot, G, Ankri, A, Chadefaux-Vekemans, B, Balcher, J, Philippe, F, Drobinski, G, Benzidia, R, Kamoun, P & Thomas, D (1997) Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease. International Journal of Cardiology 60, 295–300.CrossRefGoogle ScholarPubMed
Morgan, SL, Baggott, JE, Lee, JY & Alarcon, GS (1998) Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for Rheumatoid Arthritis: Implications for cardiovascular disease prevention. Journal of Rheumatology 25, 441–446.Google ScholarPubMed
Motulsky, AG (1996) Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. American Journal of Human Genetics 58, 17–20.Google ScholarPubMed
Moustapha, A, Naso, A, Nahlawi, M, Gupta, A, Arheart, KL, Jacobsen, DW, Robinson, K & Dennis, VW (1998) Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97, 138–141.CrossRefGoogle ScholarPubMed
Mudd, SH, Finkelstein, JD, Irreverre, F & Laster, L (1964) Homocystinuria: An enzymatic defect. Science 143, 1443–1445.CrossRefGoogle ScholarPubMed
Mudd, SH, Levy, HL & Skovby, F (1995) Disorders of transsulfuration. In The Metabolic Basis of Inherited Disease, 7th ed., pp. 1279–1327 [Scriver, CR, Beaudet, AL, Sly, WS & Valle, D, editors]. New York: McGraw-Hill.Google Scholar
Mudd, SH, Skovby, F, Levy, HL, Pettigrew, KD, Wilcken, B, Pyeritz, RE, Boers, AGHJ, Bromberg, IL, Cerone, R, Fowler, B, Grobe, H & Schimdt, H (1985) The natural history of homocystinuria due to cystathionine B-synthase deficiency. American Journal of Human Genetics 37, 1–31.Google Scholar
Murray, JC, Frazer, DR & Levene, CI (1978) The effect of pyridoxine deficiency on lysyl oxidase activity in the chick. Experiments in Molecular Pathology 28, 301–308.CrossRefGoogle ScholarPubMed
Myers, BA, Dubick, MA, Reynolds, RD & Rucker, RB (1985) Effect of vitamin B-6 (pyridoxine) deficiency on lung elastin cross-linking in perinatal and weanling rat pups. Biochemical Journal 229, 153–160.CrossRefGoogle ScholarPubMed
Naruszewicz, M, Mirkiewicz, E & Olszewski, AJ (1994) Low-density lipoprotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages. Nutrition Metabolism and Cardiovascular Disease 4, 70–77.Google Scholar
Naughton, ER, Yap, S & Mayne, PD (1998) Newborn screening for homocystinuria: Irish and world experience. European Journal of Pediatrics 157, Suppl. 2, S84–S87.CrossRefGoogle Scholar
Nishinaga, M, Ozawa, T & Shimada, K (1993) Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. Journal of Clinical Investigation 92, 1381–1386.CrossRefGoogle ScholarPubMed
Nygard, O, Nordrehaug, JE, Refsum, H, Ueland, PM, Farstad, M & Vollset, SE (1997a) Plasma homocysteine levels and mortality in patients with Coronary Heart Disease. New England Journal of Medicine 337, 230–236.CrossRefGoogle Scholar
Nygard, O, Refsum, H, Ueland, PM, Stensvold, I, Nordrehaug, JE, Kvale, G & Vollset, SE (1997b) Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition 65, 136–143.CrossRefGoogle ScholarPubMed
Nygard, O, Refsum, H, Ueland, PM & Vollset, SE (1998) Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study. American Journal of Clinical Nutrition 67, 263–270.CrossRefGoogle ScholarPubMed
Nygard, O, Vollset, SE, Refsum, H, Stensvold, I, Tverdal, A, Nordehaug, JE, Ueland, PM & Kuale, G (1995) Total plasma homocysteine and cardiovascular risk profile: The Hordaland Homocysteine Study. Journal of the American Medical Association 274, 1526–1533.CrossRefGoogle ScholarPubMed
Olszewski, AJ, Szostak, WB, Bialkowska, M, Rudnicki, S & McCully, KS (1989) Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis 75, 1–6.CrossRefGoogle ScholarPubMed
Osganian, SK, Stampfer, MJ, Spiegelman, D, Rimm, E, Cutler, JA, Feldman, HA, Montgomery, DH, Webber, LS, Lytle, LA, Bausserman, L & Nader, PR (1999) Distribution of and factors associated with serum homocysteine levels in children. Journal of the American Medical Association 281, 1189–1196.CrossRefGoogle ScholarPubMed
Outinen, PA, Sood, SK, Liaw, PCY, Seage, KD, Maeda, N, Hirsh, J, Ribau, J, Podor, TJ, Weitz, JI & Austin, RC (1998) Characterisation of the stress-inducing effects of homocysteine. Biochemistry Journal 332, 213–221.CrossRefGoogle ScholarPubMed
Perry, IH, Refsum, H, Morris, RW, Ebrahim, SB, Ueland, PM & Shaper, AG (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346, 1395–1398.CrossRefGoogle ScholarPubMed
Petri, M, Roubenoff, R, Dallal, GE, Nadeau, MR, Selhub, J & Rosenberg, IH (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348, 1120–1124.CrossRefGoogle ScholarPubMed
Quinn, CT, Griener, JC, Bottiglieri, T & Kamen, BA (1998) Methotrexate, homocysteine and seizures. Journal of Clinical Oncology 16, 393–394.CrossRefGoogle ScholarPubMed
Rasmussen, K, Moller, J, Lyngbak, M, Pedersen, HA & Dybkjer, L (1996) Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clinical Chemistry 42, 630–636.CrossRefGoogle ScholarPubMed
Ratnoff, OD (1968) Activation of Hageman factor by L-homocysteine. Science 162, 1007–1009.CrossRefGoogle Scholar
Reddy, MN (1997) Reference ranges for total homocysteine in children. Clinica Chimica Acta 262, 153–155.CrossRefGoogle ScholarPubMed
Refsum, H, Guttormsen, AB, Fiskerstrand, T & Ueland, PM (1998a) Hyperhomocysteinemia in terms of steady-state kinetics. European Journal of Pediatrics 157, Suppl. 2, S45–S49.CrossRefGoogle ScholarPubMed
Refsum, H, Helland, S & Ueland, PM (1989) Fasting plasma homocysteine as a sensitive parameter of antifolate effect: A study of psoriasis patients receiving low-dose methotrexate treatment. Clinical Pharmacological Therapy 46, 510–520.CrossRefGoogle ScholarPubMed
Refsum, H & Ueland, PM (1990) Clinical significance of pharmacological modulation of homocysteine metabolism. Trends in Pharmacological Science 11, 411–416.CrossRefGoogle ScholarPubMed
Refsum, H, Ueland, PM & Kvinsland, S (1986) Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Research 46, 5385–5391.Google ScholarPubMed
Refsum, H, Ueland, PM, Nygard, O & Vollset, SE (1998b) Homocysteine and cardiovascular disease. Annual Review of Medicine 49, 31–62.CrossRefGoogle ScholarPubMed
Refsum, H, Wesenberg, F & Ueland, PM (1991) Plasma homocysteine in children with acute lymphoblastic leukemia: Changes during a chemotherapeutic regimen including methotrexate. Cancer Research 51, 828–835.Google ScholarPubMed
Reynolds, RD, Mosser-Veillon, PB & Kant, AK (1988) Effect of age on status and metabolism of Vitamin B-6 in men. In Clinical and Physiological Applications of Vitamin B-6, pp. 109–125 [Leklem, JE & Reynolds, RD, editors]. New York: Alan R. Liss Inc.Google Scholar
Ridker, PM, Hennekens, CH, Selhub, J, Miletich, JP, Malinow, MR & Stampfer, MJ (1997) Interrelation of hyperhomocyst(e)inemia, factor V leiden, and risk of future venous thromboembolism. Circulation 95, 1777–1782.CrossRefGoogle ScholarPubMed
Ridker, PM, Manson, JE, Buring, JE, Shih, J, Martias, M & Hennekens, CH (1999) Homocysteine and risk of cardiovascular disease among postmenopausal women. Journal of the American Medical Association 281, 1817–1821.CrossRefGoogle ScholarPubMed
Riggs, KM, Spiro, A, Tucker, K & Rush, D (1996) Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition 63, 306–314.CrossRefGoogle ScholarPubMed
Rimm, EB, Willett, WC, Hu, FB, Sampson, L, Colditz, GA, Manson, JE, Hennekens, C & Stampfer, MJ (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. Journal of the American Medical Association 279, 359–364.CrossRefGoogle ScholarPubMed
Rinehart, JF & Greenberg, LD (1949) Arteriosclerotic lesions in pyridoxine-deficient monkeys. American Journal of Pathology 25, 481–491.Google ScholarPubMed
Robinson, K, Arheart, K, Refsum, H, Brattstrom, L, Boers, G, Ueland, P, Rubba, P, Palma-Reis, R, Meleady, R, Daly, L, Witteman, J & Graham, I (1998) Low circulating folate and vitamin B6 concentrations — Risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 97, 437–443.CrossRefGoogle ScholarPubMed
Robinson, K, Mayer, EL, Miller, DP, Green, R, van Lente, F, Gupta, A, Kottre-Marchant, K, Savon, SR, Selhub, J, Nissen, SE, Kutner, M, Topol, EJ & Jacobsen, DW (1995) Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 92, 2825–2830.CrossRefGoogle ScholarPubMed
Rodgers, GM & Conn, MT (1990) Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75, 895–901.CrossRefGoogle ScholarPubMed
Rodgers, GM, Fryer, RH, Wilson, BD, Gubler, DB & Fitxgerald, LA (1993) Homocysteine, a risk factor for vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Clinical Research 41, 19A.Google Scholar
Rodgers, GM & Kane, WH (1986) Activation of endogenous Factor V by a homocysteine-induced vascular endothelial cell activator. Journal of Clinical Investigation 77, 1909–1916.CrossRefGoogle ScholarPubMed
Rosenberg, IH & Rosenberg, LE (1998) The implications of genetic diversity for nutrient requirements: The case of folate. Nutrition Reviews 56, S47–S53.CrossRefGoogle ScholarPubMed
Rosenblatt, DS (1995) Inherited disorders of folate transport and metabolism. In The Metabolic Basis of Inherited Disease, 7th ed., pp. 3111–3128 [Scriver, CR, Beaudet, AL, Sly, WS & valle, D, editors]. New York: McGraw-Hill.Google Scholar
Savage, DG & Lindenbaum, J (1995) Folate-cobalamin interactions. In Folate in Health and Disease, pp. 329–360 [Bailey, LB, editor]. New York: Marcel Dekker.Google Scholar
Schroeder, HA (1955) Is atherosclerosis a conditioned pyridoxal deficiency? Journal of Chronic Disease 2, 28–41.CrossRefGoogle ScholarPubMed
Schwaninger, M, Ringleb, P, Winter, R, Kohl, B, Fiehn, W, Rieser, PA & Sack, WI (1999) Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia 40, 345–350.CrossRefGoogle ScholarPubMed
Selhub, J, Jacques, PF, Bostom, AG, D'Agostino, RB, Wilson, PWF, Belanger, AJ, O'Leary, DH, Wolf, PA, Schaefer, EJ & Rosenberg, IH (1995) Association between plasma homocysteine concentration and extracranial carotid-artery stenosis. New England Journal of Medicine 332, 286–291.CrossRefGoogle ScholarPubMed
Selhub, J, Jacques, PF, Wilson, PWF, Rush, D & Rosenberg, IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. Journal of the American Medical Association 270, 2693–2698.CrossRefGoogle Scholar
Selhub, J & Miller, J (1992) The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. American Journal of Clinical Nutrition 55, 131–138.CrossRefGoogle ScholarPubMed
Shemin, D, Lapane, KL, Bausserman, L, Kanaan, E, Kahn, S, Dworkin, L & Bostom, AG (1999) Plasma total homocysteine and hemodialysis access thrombosis: A prospective study. Journal of the American Society of Nephrology 10, 1095–1099.CrossRefGoogle ScholarPubMed
Shimakawa, T, Nieto, FJ, Malinow, MR, Chambless, LE, Schreiner, PJ & Szklo, M (1997) Vitamin intake: A possible determinant of plasma homocyst(e)ine among middle-aged adults. Annals of Epidemiology 7, 285–293.CrossRefGoogle ScholarPubMed
Shultz, TD & Hansen, CM (1998) Plasma homocysteine concentrations change with vitamin B-6 depletion and repletion in young women. Nutrition Research 18, 975–978.CrossRefGoogle Scholar
Simioni, P, Prandoni, P, Burlina, A, Tormene, D, Sardella, C, Ferrari, V, Benedetti, L & Girolami, A (1996) Hyperhomocysteinemia and deep-vein thrombosis: A case-control study. Thrombosis and Haemostasis 76, 883–886.Google ScholarPubMed
Sirrs, S, Duncan, L, Djurdjev, O, Nussbaumer, G, Ganz, G, Frohlich, J & Levin, A (1999) Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. Nephrology Dialysis Transplantation 14, 738–743.CrossRefGoogle ScholarPubMed
Slavik, M, Hyanek, J, Ellis, J & Homolka, J (1969) Typical hyperaminoaciduria after high doses of 6-azauridine triacetate. Biochemical Pharmacology 18, 1782–1784.CrossRefGoogle Scholar
Slavik, M, Smith, KJ & Blanco, O (1982) Decrease of serum pyridoxal phosphate level and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine. Biochemical Pharmacology 31, 4089–4092.CrossRefGoogle ScholarPubMed
Smolin, LA, Crenshaw, TD, Kurtycz, D & Benevenga, NJ (1983) Homocyst(e)ine accumulation in pigs fed diets deficient in vitamin B6: relationship to atherosclerosis. Journal of Nutrition 113, 2122–2133.CrossRefGoogle ScholarPubMed
Stabler, SP, Sampson, DA, Waing, L-P & Allen, RH (1997) Elevations of serum cystathionine and total homocysteine in pyridoxine-, folate-, and cobalamin-deficient rats. Nutritional Biochemistry 8, 279–289.CrossRefGoogle Scholar
Stamler, JS, Osborne, JA, Jaraki, O, Rabbani, LE, Mullins, M, Singel, D & Loscalzo, J (1993) Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and oxides of nitrogen. Journal of Clinical Investigation 91, 308–318.CrossRefGoogle ScholarPubMed
Stampfer, MJ, Malinow, MR, Willett, WC, Mewcomer, LM, Upson, B, Ullmann, D, Tishler, PV & Hennekens, CH (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. Journal of the American Medical Association 268, 877–881.CrossRefGoogle ScholarPubMed
Starkebaum, G & Harlan, JM (1986) Endothelial cell injury due to copper-catalysed hydrogen peroxide generation from homocysteine. Journal of Clinical Investigation 77, 1370–1376.CrossRefGoogle Scholar
Stehouwer, CD, Weijenberg, MP, van den, Berg M, Jakobs, C, Feskens, EJM & Kromhout, D (1998) Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men. A 10-year follow-up. Arteriosclerosis, Thrombosis and Vascular Biology 18, 1895–1901.CrossRefGoogle Scholar
Stolzenberg-Solomon, RZ, Miller, ER, Maguire, MG, Selhub, J & Appel, LJ (1999) Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. American Journal of Clinical Nutrition 69, 467–475.CrossRefGoogle Scholar
Subbarao, K, Kuchibhotla, J & Kakkar, VV (1979) Pyridoxal 5'-phosphate – A new physiological inhibitor of blood coagulation and platelet function. Biochemical Pharmacology 28, 531–534.CrossRefGoogle Scholar
Tawakol, A, Omland, T, Gerhard, M, Wu, JT & Creager, MA (1997) Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95, 1119–1121.CrossRefGoogle ScholarPubMed
Taylor, LM, DeFrang, RD, Harris, EJ & Porter, JM (1991) The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. Journal of Vascular Surgery 13, 128–136.CrossRefGoogle ScholarPubMed
Taylor, LM, Moneta, GL, Sexton, GJ, Schuff, RA, Porter, JM & The Homocysteine & Progression of Atherosclerosis Study Investigators (1999) Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. Journal of Vascular Surgery 29, 8–21.CrossRefGoogle ScholarPubMed
Tonstad, S, Joakimsen, O, Stenstad-Bugge, E, Leren, TP, Ose, L, Russell, D & Bonaa, KH (1996a) Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arteriosclerosis, Thrombosis and Vascular Biology 16, 984–991.CrossRefGoogle ScholarPubMed
Tonstad, S, Refsum, H, Siversten, M, Christpherson, B, Ose, L & Ueland, PM (1996b) Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatric Research 40, 47–52.CrossRefGoogle ScholarPubMed
Tonstad, S, Refsum, H & Ueland, PM (1997) Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia. Circulation 96, 1803–1808.CrossRefGoogle ScholarPubMed
Tsai, J-C, Perrella, MA, Yoshizumi, M, Hseith, C-M, Haber, E, Schlegel, R & Lee, M-E (1994) Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proceedings of the National Academy of Sciences USA 91, 6369–6373.CrossRefGoogle ScholarPubMed
Tsai, JC, Wang, H, Perella, MA, Yoshizumi, M, Sibinga, NES, Tan, LC, Haber, E, Chang, THT, Schlegel, R & Lee, ME (1996) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. Journal of Clinical Investigation 97, 146–153.CrossRefGoogle ScholarPubMed
Ubbink, JB, Becker, PJ, Vermaak, WJH & Delport, R (1995) Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clinical Chemistry 41, 1033–1037.CrossRefGoogle Scholar
Ubbink, JB, Delport, R & Vermaak, WJH (1996) Plasma homocysteine concentrations in a population with a low coronary heart disease prevalence. Journal of Nutrition 126, 1254S–1257S.CrossRefGoogle Scholar
Ubbink, JB, Vermaak, WJH, van der, Merwe A, Becker, PJ, Delport, R & Potgieter, HC (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. Journal of Nutrition 124, 1927–1933.CrossRefGoogle ScholarPubMed
Ueland, PM & Refsum, H (1989) Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. Journal of Laboratory and Clinical Medicine 114, 473–501.Google ScholarPubMed
Ueland, PM, Refsum, H, Stabler, SP, Malinow, R, Andersson, A & Allen, RH (1993) Total homocysteine in plasma or serum: Methods and clinical applications. Clinical Chemistry 39, 1764–1779.CrossRefGoogle ScholarPubMed
Upchurch, GR Jr, Welch, GN, Freedman, JE & Loscalzo, J (1995) Homocysteine attenuates endothelial glutathione peroxidase and thereby potentiates peroxide-mediated cell injury. Circulation 92, 1086.Google Scholar
Upchurch, GR, Welch, GN, Fabian, AJ, Freedman, JE, Johnson, JL, Keaney, JF & Loscalzo, J (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. Journal of Biological Chemistry 272, 17012–17017.CrossRefGoogle ScholarPubMed
Upchurch, GR, Welch, GN & Loscalzo, J (1996) Homocysteine, EDRF and endothelial function. Journal of Nutrition 126, 1290S–1294S.CrossRefGoogle ScholarPubMed
van den, Berg M, Boers, GH, Franken, DG, Blom, HJ, van Kamp, GJ, Jakobs, C, Rauwerda, JA, Kluft, C & Stehouwert, CD (1995) Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. European Journal of Clinical Investigation 25, 176–181.Google Scholar
van den, Berg M, Stehouwer, CD, Bierdrager, E & Rauwerda, JA (1996) Plasma homocysteine and severity of atherosclerosis in young adults with lower-limb atherosclerotic disease. Arteriosclerosis, Thrombosis and Vascular Biology 16, 165–171.CrossRefGoogle Scholar
van der, Mooren MJ, Wouters, MGAJ, Blom, HJ, Schellekens, LA, Eskes, TKAB & Rolland, R (1994) Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. European Journal of Clinical Investigation 24, 357–360.Google Scholar
van Guldener, C, Janssen, MJFM, Lambert, J, Wee, PM, Donker, AJM & Stehouwer, CDA (1998) Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: No change in endothelial function after long-term therapy. Peritoneal Dialysis International 18, 282–289.Google ScholarPubMed
van Guldener, C, Kulik, W, Berger, R, Dijkstra, DA, Jakobs, C, Reijngoud, DJ, Donker, AJM, Stehouwer, CDA & de Meer, K (1999) Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney International 56, 1064–1071.CrossRefGoogle ScholarPubMed
Velury, S & Howell, SB (1988) Measurement of plasma thiols after derivitisation with monobromobimane. Journal of Chromatography 424, 141–146.CrossRefGoogle Scholar
Verhoef, P, Hennekens, CH, Allen, RH, Stabler, SP, Willett, WC & Stampfer, MJ (1997a) Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. American Journal of Cardiology 79, 799–801.CrossRefGoogle ScholarPubMed
Verhoef, P, Hennekens, CH, Malinow, MR, Kok, FJ, Willett, WC & Stampfer, MJ (1994) A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25, 1924–1930.CrossRefGoogle ScholarPubMed
Verhoef, P, Kok, FJ, Kruyssen, DACM, Schouten, EG, Witteman, JCM, Grobbee, DE, Ueland, PM & Refsum, H (1997b) Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arteriosclerosis, Thrombosis and Vascular Biology 17, 989–995.CrossRefGoogle ScholarPubMed
Verhoef, P, Meleady, R, Daly, LE, Graham, IM, Robinson, K & Boers, GHJ (1999) Homocysteine, vitamin status and risk of vascular disease – Effects of gender and menopausal status. European Heart Journal 20, 1234–1244.CrossRefGoogle ScholarPubMed
Verhoef, P, Stampfer, MJ, Buring, JE, Gaziano, JM, Allen, RH, Stabler, SP, Reynolds, RD, Kok, FJ, Hennekens, CH & Willett, WC (1996) Homocysteine metabolism and risk of myocardial-infarction –– Relation with vitamin-B6, vitamin-B12, and folate. American Journal of Epidemiology 143, 845–859.CrossRefGoogle Scholar
Vilaseca, MA, Moyano, D, Ferrer, I & Artuch, R (1997) Total homocysteine in pediatric patients. Clinical Chemistry 43, 690–692.CrossRefGoogle ScholarPubMed
Voutilainen, S, Alfthan, G, Nyssonen, K, Salonen, R & Salonen, JT (1998) Association between elevated plasma total homocysteine and increased common carotid artery wall thickness. Annals of Medicine 30, 300–306.CrossRefGoogle ScholarPubMed
Wald, NJ, Watt, HC, Law, MR, Weir, DG, McPartlin, J & Scott, JM (1998) Homocysteine and ischemic heart disease: Results of a prospective study with implications regarding prevention. Archives of Internal Medicine 158, 862–867.CrossRefGoogle ScholarPubMed
Wall, RT, Harlan, JM, Harker, LA & Striker, GE (1980) Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury. Thrombosis Research 18, 113–121.CrossRefGoogle Scholar
Wang, J, Dudman, NPB & Wilcken, DEL (1993) Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells. Thrombosis and Haemostasis 70, 1047–1052.Google ScholarPubMed
Ward, M, McNulty, H, McPartlin, J, Strain, JJ, Weir, DG & Scott, JM (1997) Plasma homocysteine, a risk factor for cardiovascular disease can be effectively lowered by physiological amounts of folic acid. Quarterly Journal of Medicine 90, 519–524.CrossRefGoogle Scholar
Welch, GN, Upchurch, G & Loscalzo, J (1997) Hyperhomocyst(e)inemia and atherothrombosis. Annals of the New York Academy of Sciences 811, 48–59.CrossRefGoogle ScholarPubMed
Wiklund, O, Fager, G, Andersson, A, Lundstan, U, Masson, P & Hultberg, B (1996) N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein (a) levels. Atherosclerosis 119, 99–106.CrossRefGoogle Scholar
Wilcken, DEL, Gupta, VJ & Betts, AK (1981) Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clinical Science 61, 743–749.CrossRefGoogle ScholarPubMed
Wouters, MG, Moorrees, MT, van der, Mooren MJ, Blom, HJ, Boers, GHJ, Schellekens, LA, Thomas, CMG & Eskes, TKAB (1995) Plasma homocysteine and menopausal status. European Journal of Clinical Investigation 25, 801–805.CrossRefGoogle ScholarPubMed
Wu, LL, Wu, J, Hunt, SC, James, BC, Vincent, GM, Williams, RR & Hopkins, PN (1994) Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clinical Chemistry 40, 552–561.CrossRefGoogle ScholarPubMed
Yoo, J-H, Park, J-E, Hong, K-P, Lee, S-H, Kim, D-K, Lee, W-R & Park, S-C (1999) Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans. Thrombosis Research 94, 45–52.CrossRefGoogle ScholarPubMed
Young, PB, Kennedy, S, Molloy, AM, Scott, JM, Weir, DG & Kennedy, DG (1997) Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs. Atherosclerosis 129, 67–71.CrossRefGoogle ScholarPubMed